P030039S018

None

FDA Premarket Approval P030039 S018

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP030039S018
Classification NameNone
Applicant
PMAP030039
SupplementS018

Supplemental Filings

Supplement NumberDateSupplement Type
P030039Original Filing
S027 2021-09-28 30-day Notice
S026 2021-04-21 Normal 180 Day Track
S025 2020-04-17 Real-time Process
S024
S023 2018-05-03 Real-time Process
S022 2018-02-20 30-day Notice
S021 2018-01-25 Special (immediate Track)
S020 2017-12-04 Normal 180 Day Track No User Fee
S019 2015-10-16 30-day Notice
S018
S017
S016 2010-06-01 Special (immediate Track)
S015 2010-03-02 Special (immediate Track)
S014 2009-09-04 Real-time Process
S013 2009-03-17 135 Review Track For 30-day Notice
S012 2008-11-07 30-day Notice
S011 2008-08-29 Special (immediate Track)
S010 2008-07-01 Real-time Process
S009 2008-03-24 30-day Notice
S008 2007-11-15 30-day Notice
S007 2007-10-31 30-day Notice
S006
S005 2007-06-25 30-day Notice
S004 2006-04-05 Normal 180 Day Track
S003 2006-02-02 Special (immediate Track)
S002 2006-01-17 Normal 180 Day Track No User Fee
S001 2003-12-18 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
35413765583415 P030039 024

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.